CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the use of ultra-high dose-rate heavy ion therapy, specifically with neon ions, to treat resistant tumors like glioblastoma. By leveraging the FLASH effect, the aim is to enhance tumor control while minimizing damage to normal tissues, potentially revolutionizing cancer treatment.
Charged particle therapy is generally acknowledged as the most advanced type of radiotherapy (RT).
Particle therapy patients are treated either with high-energy protons or 12C-ions, but there is a general agreement that heavier ions would be highly beneficial in treating extremely resistant, hypoxic and lethal tumors, such as glioblastoma (GBM).
Unfortunately, the use of very heavy ions is constrained by their excessive normal tissue toxicity.A way to enable very heavy ion therapy with acceptabl…
GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
